International Journal of Infection

Published by: Kowsar

Effects of Dexamethasone on Clinical Outcome in Patients with Severe Crimean-Congo Hemorrhagic Fever

Mohammad Hashemi-Shahri 1 , Batool Sharifi-Mood 1 , * , Alireza Ansari Moghaddam 2 and Shahabodin Mashaei 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Boo-Ali Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: July 2017, 4 (3); e14587
  • Published Online: June 12, 2017
  • Article Type: Research Article
  • Received: January 4, 2017
  • Accepted: January 12, 2017
  • DOI: 10.5812/iji.14587

To Cite: Hashemi-Shahri M, Sharifi-Mood B, Ansari Moghaddam A, Mashaei S. Effects of Dexamethasone on Clinical Outcome in Patients with Severe Crimean-Congo Hemorrhagic Fever, Int J Infect. 2017 ; 4(3):e14587. doi: 10.5812/iji.14587.

Abstract
Copyright © 2017, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004; 64(3): 145-60[DOI][PubMed]
  • 2. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med. 2007; 10(2): 204-14[PubMed]
  • 3. Metanat M, Sharifi-Mood B, Masoud S. Crimean-Congo Hemorrhagic Fever: A Reemerging Disease. Arch Clin Infect Dis. 2014; 9(1)
  • 4. Metanat M, Sharifi-Mood B, Alavi-Naini R, Kermansaravi F, Hamzehnezhad M. Crimean-Congo Hemorrhagic Fever and Hypertention: A Case Report. Arch Clin Infect Dis. 2014; 9(1)
  • 5. Rakhshani M, Abedi-poor F, Noori-Jangi M, Khoorgami P, Hajalizadeh A, Kooshki M, et al. A Five-Member Family With Crimean-Congo Hemorrhagic Fever; A Case Series Study. Int J Infect. 2014; 1(1)
  • 6. Tabatabaei SM, Hassanzehi A, Pakzad A, Mohammdi M, Madani A. Factors Influencing Crimean-Congo Hemorrhagic Fever Risk Perceptions in the General Population, Southeast Iran. Int J Infect. 2014; 1(1)[DOI]
  • 7. Sharifi-Mood B, Metanat M, Hashemi Shahri SM, Salehi M, Khalili M. Crimean-Congo Hemorrhagic Fever in Children in Southeast of Iran. Int J Infect. 2014; 1(3)[DOI]
  • 8. Hashemi-Shahri SM, Sharifi-Mood B, Metanat M. Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever. Int J Infect. 2014; 1(3)[DOI]
  • 9. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
  • 10. Sharifi-Mood B, Metanat M, Hashemi-Shahri SM, Mardani M, Hashemi SA, Fayyaz-Jahani F. Crimean-Congo hemorrhagic fever following consumption of uncooked liver: case series study. Iran J Clin Infect Dis. 2011; 6(3): 128-30
  • 11. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006; 12(6): 551-4[DOI][PubMed]
  • 12. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004; 39(2): 284-7[DOI][PubMed]
  • 13. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin Infect Dis. 2003; 36(12): 1613-8[DOI][PubMed]
  • 14. Mirazimi A. Crimean-Congo Hemorrhagic Fever: A Global Perspective. 2007;
  • 15. Metanat M, Sharifi-Mood B, Salehi M, Alavi-Naini R. Clinical outcome in Crimen-Congo hemorrhagic Fever: A five years experience in the treatment of patients in oral Ribavirin. Int J Virol. 2006; 2(1): 21-2
  • 16. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med. 2009; 12(2): 151-3
  • 17. Dilber E, Cakir M, Erduran E, Koksal I, Bahat E, Mutlu M, et al. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever. Trop Doct. 2010; 40(1): 27-30[DOI][PubMed]
  • 18. Erduran E, Bahadir A, Palanci N, Gedik Y. The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma. J Pediatr Hematol Oncol. 2013; 35(1)-24[DOI][PubMed]
  • 19. Sharifi-Mood B, Alavi-Naini R, Metanat M, Mohammadi M, Shakeri A, Amjadi A. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia. Trop Doct. 2013; 43(2): 49-53[DOI][PubMed]
  • 20. Izadi S, Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis. 2009; 62(1): 11-5
  • 21. Centers for Disease C. Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb Mortal Wkly Rep. 1983; 32 Suppl 2: 27S-38S[PubMed]
  • 22. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis. 2010; 4(10)
  • 23. Weber F, Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 2008; 19(5-6): 395-404[DOI][PubMed]
  • 24. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Avsic-Zupanc T. Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. Clin Vaccine Immunol. 2010; 17(7): 1086-93[DOI][PubMed]
  • 25. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006; 193(7): 941-4[DOI][PubMed]
  • 26. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006; 36(4): 272-6[DOI][PubMed]
  • 27. Kaya S, Elaldi N, Kubar A, Gursoy N, Yilmaz M, Karakus G, et al. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis. 2014; 14: 416[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments